Showing 17,081 - 17,100 results of 45,766 for search '(( 5 ((nm decrease) OR (mean decrease)) ) OR ( 50 ((we decrease) OR (a decrease)) ))', query time: 1.44s Refine Results
  1. 17081
  2. 17082

    A Pilot Randomized Placebo Controlled Trial of Electroacupuncture for Women with Pure Stress Urinary Incontinence by Huanfang Xu (2558446)

    Published 2016
    “…The differences between groups in the decrease from baseline of 72-hour IEF became statistically significant at week 30 with a median decrease of 3.25 g (IQR: 1.25–5.69) in the EA group, and a median decrease of 1.00 g (IQR: -0.69–+2.88) in the sham EA group (p = 0.01). …”
  3. 17083
  4. 17084
  5. 17085
  6. 17086
  7. 17087
  8. 17088

    Reduction of glucose in the culture medium sensitizes breast cancer cells to metformin treatment but not human mammary epithelial MCF10A cells. by Yongxian Zhuang (634693)

    Published 2014
    “…<p>All cells were treated with different concentrations of metformin (0, 2, 4, 8, 16 mM) in medium containing different levels of glucose (0, 2.5, 5, 10, 15, 25 mM) for one day. Percentage of dead cells was determined using Sytox Green staining. …”
  9. 17089
  10. 17090
  11. 17091
  12. 17092
  13. 17093

    FOXO3a down-regulates <i>PRNP</i> expression by binding to its promoter. by Ting Liu (45625)

    Published 2013
    “…(C) and (D) EMSA showing that FOXO3a can bind to the human <i>PRNP</i> promoter. Compared with the control (lanes 1 and 2), FOXO3a bound to the <i>PRNP</i> promoter in a dose-dependent manner (lanes 3, 4 and 5), and this binding was abolished by a 50-fold excess of unlabeled probes (lanes 6 and 7) and mutation of the FOXO binding site (lanes 8 and 9) results in low affinity for FOXO3a. …”
  14. 17094
  15. 17095
  16. 17096
  17. 17097
  18. 17098
  19. 17099
  20. 17100